MCK
McKesson Corporation
MCK has slightly lower modeled downside risk, despite its lower overall score.
UNH
UnitedHealth Group Incorporated
UNH has a slight edge over MCK overall, supported by stronger modeled upside and stronger valuation.
MCK Fundamentals
| Metric | Status |
|---|---|
| Stable | |
| Healthy | |
| Stable | |
| Strong |
MCK's profitability and balance sheet are currently healthy, and its revenue and cash flow are stable.
UNH Fundamentals
| Metric | Status |
|---|---|
| Stable | |
| Stable | |
| Healthy | |
| Healthy |
UNH's cash flow and balance sheet are currently healthy, and its revenue and profitability are stable.
MCK PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Cheap | 17x | $654 | -39% |
| Forward | 22x | $1,077 | — |
| Fair | 26x | $1,019 | -5.4% |
| Current | 28x | $1,077 | — |
| Expensive | 31x | $1,206 | +12% |
Historical ranges are pointers, not guarantees.
MCK has the edge over UNH in the historical PE scenario, which offers more potential upside but is not a forecast.
UNH PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Forward | 18x | $405 | — |
| Cheap | 19x | $325 | -20% |
| Fair | 23x | $410 | +1.2% |
| Current | 23x | $405 | — |
| Expensive | 30x | $526 | +30% |
Historical ranges are pointers, not guarantees.
UNH's PE is in its fair range at 23x. If earnings grow as analysts expect, today's price would be 18x next year's earnings, in its cheap range.
MCK Forward outlook
| Metric | Outlook |
|---|---|
| Strongly improving | |
| Growth | |
| Growth | |
| Stable | |
| Limited | |
| High |
Analysts expect earnings and revenue growth for MCK, with profitability holding steady.
UNH Forward outlook
| Metric | Outlook |
|---|---|
| Strongly improving | |
| Strong growth | |
| Stable | |
| Improving | |
| Moderate | |
| Low |
Analysts expect UNH's earnings to grow and its profitability to improve, with its revenue holding steady. However, they disagree widely on these estimates.
MCK Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $48.95 | +26% |
| Q3 2026 | $38.80 | +21% |
| Q2 2026 | $37.28 | +49% |
| Q1 2026 | $38.38 | +49% |
| Q4 2025 | $34.66 | +59% |
| Q3 2025 | $32.02 | +66% |
| Q2 2025 | $24.97 | +12% |
| Q1 2025 | $25.72 | +15% |
| Q4 2024 | $21.85 | -0.9% |
MCK has the edge over UNH on earnings, with more consistent year-over-year improvement.
UNH Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $22.65 | +29% |
| Q3 2026 | $17.55 | -8.5% |
| Q2 2026 | $15.58 | -33% |
| Q1 2026 | $13.28 | -44% |
| Q4 2025 | $13.23 | -15% |
| Q3 2025 | $19.17 | +25% |
| Q2 2025 | $23.09 | +53% |
| Q1 2025 | $23.89 | +46% |
| Q4 2024 | $15.51 | -35% |
UNH's earnings per share have fallen from their peak: $17.55 over the past year, against $23.89 in early 2025.
MCK Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $111B | +7.6% |
| Q2 2026 | $105.4B | +7.7% |
| Q1 2026 | $96.3B | +6% |
| Q4 2025 | $106.2B | +11% |
| Q3 2025 | $103.2B | +10% |
| Q2 2025 | $97.8B | +23% |
| Q1 2025 | $90.8B | +19% |
| Q4 2024 | $95.3B | +18% |
MCK has the edge over UNH on sales, with more consistent year-over-year improvement.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 1.4% | +0.1 points |
| Q2 2026 | 1.3% | +0.2 points |
| Q1 2026 | 2.2% | +0.5 points |
| Q4 2025 | 1.5% | +0.3 points |
| Q3 2025 | 1.4% | +0.7 points |
| Q2 2025 | 1.1% | -0.2 points |
| Q1 2025 | 1.8% | +0.2 points |
| Q4 2024 | 1.3% | +0.5 points |
MCK's operating margin was 1.4% last quarter, about level with the same quarter a year ago.
UNH Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $112.7B | -0.4% |
| Q2 2026 | $112B | +0.4% |
| Q1 2026 | $111.7B | +2% |
| Q4 2025 | $113.2B | +12% |
| Q3 2025 | $113.2B | +12% |
| Q2 2025 | $111.6B | +13% |
| Q1 2025 | $109.6B | +9.8% |
| Q4 2024 | $100.8B | +6.8% |
UNH's revenue has held roughly level: $113B last quarter, about level with the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 5.8% | +2 points |
| Q2 2026 | 7.1% | +2.5 points |
| Q1 2026 | 8.1% | -0.3 points |
| Q4 2025 | 0.3% | -7.4 points |
| Q3 2025 | 3.8% | -4.8 points |
| Q2 2025 | 4.6% | -3.4 points |
| Q1 2025 | 8.3% | +0.4 points |
| Q4 2024 | 7.7% | -0.4 points |
UNH has the edge over MCK on profitability, with a higher operating margin.
MCK Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $3B | +30% |
| Q2 2026 | -$332M | +$697M |
| Q1 2026 | $3.3B | -56% |
| Q4 2025 | $1.1B | +$3.6B |
| Q3 2025 | $2.3B | +18% |
| Q2 2025 | -$1B | +$457M |
| Q1 2025 | $7.6B | +91% |
| Q4 2024 | -$2.5B | -1630% |
MCK has the edge over UNH on cash flow, with more consistent year-over-year improvement.
UNH Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $4.3B | -16% |
| Q2 2026 | $10.3B | +63% |
| Q1 2026 | $8.1B | +79% |
| Q4 2025 | $160M | -89% |
| Q3 2025 | $5.1B | -61% |
| Q2 2025 | $6.3B | +6.9% |
| Q1 2025 | $4.6B | +1037% |
| Q4 2024 | $1.5B | +$7.6B |
UNH still generates free cash flow, though less than at its 2022 peak: $22.8B over the past year.
MCK Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | -2.1% | -2.5M shares |
| 1 year | -6.2% | -7.7M shares |
| 3 years | -13% | -18.1M shares |
| 5 years | -25% | -39.1M shares |
| Available history | -35% | -63.3M shares |
MCK has the edge over UNH on shareholder dilution, with a more favorable share count trend.
| Quarter | Spent |
|---|---|
| Q3 2026 | $894M |
| Q2 2026 | $2.5B |
| Q1 2026 | $2.7B |
| Q4 2025 | $680M |
| Q3 2025 | $818M |
| Q2 2025 | $581M |
| Q1 2025 | $300M |
| Q4 2024 | $827M |
MCK spent $6.8B buying back its own shares over the past year, up 168% from the year before.
UNH Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | -0.4% | -4M shares |
| 1 year | -0.7% | -6M shares |
| 3 years | -3.6% | -34M shares |
| 5 years | -5.5% | -53M shares |
| Available history | -6.6% | -64M shares |
UNH has 902M diluted shares, down 0.7% from a year ago, with $5B in buybacks over the past year.
| Quarter | Spent |
|---|---|
| Q3 2026 | $3.4B |
| Q2 2026 | $1.6B |
| Q1 2026 | — |
| Q4 2025 | — |
| Q3 2025 | — |
| Q2 2025 | $2.5B |
| Q1 2025 | $3B |
| Q4 2024 | $5B |
UNH spent $5B buying back its own shares over the past year, down 52% from the year before.
MCK Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | 0.4x | Very low |
| Q2 2026 | 0.6x | Very low |
| Q1 2026 | 0.4x | Very low |
| Q4 2025 | 0.6x | Very low |
| Q3 2025 | 0.6x | Very low |
| Q2 2025 | 1.1x | Healthy |
| Q1 2025 | -0.0x | Net Cash |
| Q4 2024 | 1.5x | Healthy |
MCK has the edge over UNH on leverage, with a lower net debt burden relative to earnings.
UNH Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | 1.7x | Healthy |
| Q2 2026 | 1.7x | Healthy |
| Q1 2026 | 2.2x | Moderate |
| Q4 2025 | 2.3x | Moderate |
| Q3 2025 | 1.7x | Healthy |
| Q2 2025 | 1.5x | Healthy |
| Q1 2025 | 1.3x | Healthy |
| Q4 2024 | 1.4x | Healthy |
UNH's net debt is about 1.7 years of its operating earnings (EBITDA), about the same as a year ago.
MCK Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 76.3 | Overbought |
| Stochastic | 82.8 | Overbought |
MCK's weekly RSI is 76 (overbought) and its Stochastic is 83 (overbought).
UNH Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 56.4 | Neutral |
| Stochastic | 60.0 | Neutral |
UNH's weekly RSI is 56 (neutral) and its Stochastic is 60 (neutral).
MCK PE vs Healthcare Sector
| Metric | MCK | Sector median | Relative |
|---|---|---|---|
| PE | 28x | 26x | 7.4% above |
| PE % | 67 | 29 | 38 pts above |
MCK is trading at 28x earnings, in line with the Healthcare sector's median of 26x.
UNH PE vs Healthcare Sector
| Metric | UNH | Sector median | Relative |
|---|---|---|---|
| PE | 23x | 26x | 11% below |
| PE % | 47 | 29 | 18 pts above |
UNH has the edge over MCK on valuation relative to its sector.
MCK Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $980.7 | 9.8% above |
| 20 week MA | $906.6 | 19% above |
| 50 week MA | $865.9 | 24% above |
| 100 week MA | $781.2 | 38% above |
| 200 week MA | $628.8 | 71% above |
MCK has the edge over UNH on trend strength, trading above more of its moving averages.
UNH Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $394.2 | 2.8% above |
| 20 week MA | $400.5 | 1.2% above |
| 50 week MA | $361.2 | 12% above |
| 100 week MA | $376.0 | 7.8% above |
| 200 week MA | $446.6 | 9.3% below |
UNH has bounced recently, but its long-term trend is still down: it's above its 8-, 20-, 50- and 100-week averages, but 9.3% below its 200-week average.
MCK Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $139.4 | $170.8 | +22% |
| 2021 | $170.8 | $240.8 | +41% |
| 2022 | $240.8 | $383.7 | +59% |
| 2023 | $383.7 | $463.0 | +21% |
| 2024 | $463.0 | $576.6 | +25% |
| 2025 | $576.6 | $828.3 | +44% |
| 2026 YTD | $828.3 | $1,077.1 | +30% |
MCK has the edge over UNH on returns for 2026, with the stronger performance.
UNH Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $296.0 | $340.8 | +15% |
| 2021 | $340.8 | $495.4 | +45% |
| 2022 | $495.4 | $531.3 | +7.3% |
| 2023 | $531.3 | $526.5 | -0.9% |
| 2024 | $526.5 | $510.0 | -3.1% |
| 2025 | $510.0 | $331.8 | -35% |
| 2026 YTD | $331.8 | $405.1 | +22% |
UNH has finished three years in a row lower, and it's up 22% so far in 2026.